Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Syphilis imitating urticarial vasculitis

Hideaki Miyachi, Toshibumi Taniguchi and Hiroyuki Matsue
CMAJ December 16, 2019 191 (50) E1384; DOI: https://doi.org/10.1503/cmaj.190469
Hideaki Miyachi
Department of Dermatology (Miyachi, Matsue), Graduate School of Medicine; Department of Infectious Diseases (Taniguchi), Chiba University Hospital, Chiba-shi, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshibumi Taniguchi
Department of Dermatology (Miyachi, Matsue), Graduate School of Medicine; Department of Infectious Diseases (Taniguchi), Chiba University Hospital, Chiba-shi, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Matsue
Department of Dermatology (Miyachi, Matsue), Graduate School of Medicine; Department of Infectious Diseases (Taniguchi), Chiba University Hospital, Chiba-shi, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

See related article at www.cmaj.ca/lookup/doi/10.1503/cmaj.191075

A 27-year-old previously healthy woman presented with a 2-month history of recurrent raised pruritic erythematous plaques resembling urticaria that persisted for more than 24 hours (Figure 1). She was otherwise asymptomatic, with no history of fever or mucosal lesions. Previous treatments with orally administered H1 antihistamines and corticosteroids were ineffective. Skin biopsy showed perivascular inflammatory cell infiltration with some nuclear debris and swelling of endothelial cells involving postcapillary venules, whereas plasma cell infiltration was nearly absent (Appendix 1, Supplementary Figure 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.190469/-/DC1). Direct immunofluorescence showed the deposition of complement and fibrinogen around blood vessels and in the dermal–epidermal junction, consistent with urticarial vasculitis. However, complement levels were unremarkable, and the C1q solid-phase test for immune complexes was negative, excluding hypocomplementemic urticarial vasculitis. Autoantibodies associated with connective tissue diseases were not detected.

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Raised pruritic erythematous plaques resembling urticaria in a 27-year-old woman with secondary syphilis.

Serologic tests for HIV, hepatitis B virus and hepatitis C virus were negative; however, the rapid plasma reagin test was positive (titer, 1:128), and the Treponema pallidum hemagglutination assay was reactive. Furthermore, immunohistochemistry with anti-Treponema antibody showed marked invasion of Treponema into the epidermis, indicating that the skin lesions were caused by syphilis and confirming the diagnosis of secondary syphilis (Appendix 1, Supplementary Figure 2). With orally administered amoxicillin (6 g/d) and probenecid (1 g/d) for 4 weeks, the skin lesions resolved. This effective combination of drugs is used in Japan, as intramuscular benzathine penicillin is not available.1

Syphilis is still prevalent, with increasing incidence worldwide. 2 Typical dermatologic findings of secondary syphilis are nonpruritic diffuse macules or papules with palmoplantar involvement; however, the rash can be quite variable.2 Syphilis imitates various skin diseases, such as drug eruptions, psoriasis, pityriasis rosea and many others, making diagnosis challenging.3 This case highlights the importance of considering serologic testing for syphilis when patients present with skin lesions that may be atypical for syphilis. Furthermore, skin biopsy and immunohistochemistry with anti-Treponema antibody are useful for diagnosing cutaneous lesions of secondary syphilis,4 which may otherwise be misdiagnosed as a nonspecific rash.

Footnotes

  • Competing interests: Toshibumi Taniguchi accepts consultancy fees from ViiV Healthcare K.K., MSD K.K., Janssen Pharmaceutical K.K. and Torii Pharmaceutical Co. Ltd.; a research grant from MSD K.K.; and a speaking fee from MSD K.K., Torii Pharmaceutical Co. Ltd., Astellas Pharma Inc., Pfizer Japan Inc. and Shionogi & Co., Ltd. No other competing interests were declared.

  • This article has been peer reviewed.

  • The authors have obtained patient consent.

References

    1. Tanizaki R,
    2. Nichijima T,
    3. Aoki T,
    4. et al
    . High-dose oral amoxicillin plus probenecid is highly effective for syphillis in patients with HIV infection. Clin Infect Dis 2015; 61:177–83.
    1. Hook EW 3rd.
    Syphilis [published erratum in Lancet 2019;393:986]. Lancet 2017;389:1550–7.
    1. Cossman JP,
    2. Fournier JB
    . Frequency of syphilis diagnoses by dermatologists. JAMA Dermatol 2017;153:718–9.
    1. Martín-Ezquerra G,
    2. Fernandez-Casado A,
    3. Barco D,
    4. et al
    . Treponema pallidum distribution patterns in mucocutaneous lesions of primary and secondary syphilis: an immunohistochemical and ultrastructural study. Hum Pathol 2009; 40: 624–30.

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire